Literature DB >> 23949313

No difference between posaconazole and fluconazole antifungal prophylaxis and mycological diagnostics except costs in patients undergoing AML chemotherapy: a 1-year "real-life" evaluation.

Hartmut Bertz1, Kathrin Drognitz, Michael Lübbert.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23949313     DOI: 10.1007/s00277-013-1854-6

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  5 in total

1.  Efficacy of antifungal prophylaxis with oral suspension posaconazole during induction chemotherapy of acute myeloid leukemia.

Authors:  Karin G Schrenk; Ulf Schnetzke; Katy Stegemann; Marie von Lilienfeld-Toal; Andreas Hochhaus; Sebastian Scholl
Journal:  J Cancer Res Clin Oncol       Date:  2015-03-24       Impact factor: 4.553

2.  A Single Center Experience for Antifungal Prophylaxis in Patients with Acute Myelogenous Leukemia.

Authors:  Gökhan Metan; Zeynep Türe; Çiğdem Pala; Leylagül Kaynar; Afra Yıldırım; Ferhan Elmalı; Nuri Tutar; Nuran Yozgat; Bülent Eser
Journal:  Indian J Hematol Blood Transfus       Date:  2014-11-02       Impact factor: 0.900

Review 3.  Lichtheimia Infection in a Lymphoma Patient: Case Report and a Brief Review of the Available Diagnostic Tools.

Authors:  Stefan Zimmerli; Ralf Bialek; Igor W Blau; Andreas Christe; Cornelia Lass-Flörl; Elisabeth Presterl
Journal:  Mycopathologia       Date:  2016-04-26       Impact factor: 2.574

Review 4.  Therapeutic Drug Monitoring of Posaconazole: an Update.

Authors:  Bart G J Dekkers; Martijn Bakker; Kim C M van der Elst; Marieke G G Sturkenboom; Anette Veringa; Lambert F R Span; Jan-Willem C Alffenaar
Journal:  Curr Fungal Infect Rep       Date:  2016-05-07

Review 5.  Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).

Authors:  Sibylle C Mellinghoff; Jens Panse; Nael Alakel; Gerhard Behre; Dieter Buchheidt; Maximilian Christopeit; Justin Hasenkamp; Michael Kiehl; Michael Koldehoff; Stefan W Krause; Nicola Lehners; Marie von Lilienfeld-Toal; Annika Y Löhnert; Georg Maschmeyer; Daniel Teschner; Andrew J Ullmann; Olaf Penack; Markus Ruhnke; Karin Mayer; Helmut Ostermann; Hans-H Wolf; Oliver A Cornely
Journal:  Ann Hematol       Date:  2017-12-07       Impact factor: 3.673

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.